About: Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children
Creator	Choi, Hee Kim, Yeo Lee, Na
topic	covid:d443900c4eef6494eeaf138236a955c0a040f3bd#this
Source	Medline; PMC
abstract	PURPOSE: The aims of this study were to compare serum procalcitonin (PCT) levels between febrile children with Kawasaki disease (KD) and those with bacterial or viral infections, and assess the clinical usefulness of PCT level in predicting KD. METHODS: Serum PCT levels were examined in febrile pediatric patients admitted between August 2013 and August 2014. The patients were divided into 3 groups as follows: 49 with KD, 111 with viral infections, and 24 with bacterial infections. RESULTS: The mean PCT level in the KD group was significantly lower than that in the bacterial infection group (0.82±1.73 ng/mL vs. 3.11±6.10 ng/mL, P=0.002) and insignificantly different from that in the viral infection group (0.23±0.34 ng/mL,P=0.457). The mean erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level in the KD group were significantly higher than those in the viral and bacterial infection groups (P<0.001 and P<0.001 for ESR, P<0.001 and P=0.005 for CRP, respectively). The proportion of patients in the KD group with PCT levels of >1.0 ng/mL was significantly higher in the nonresponders to the initial intravenous immunoglobulin treatment than in the responders (36% vs. 8%, P=0.01). CONCLUSION: PCT levels may help to differentiate KD from bacterial infections. A combination of disease markers, including ESR, CRP, and PCT, may be useful for differentiating between KD and viral/bacterial infections.
has issue date	2017-04-25(xsd:dateTime)
bibo:doi	10.3345/kjp.2017.60.4.112
bibo:pmid	28461824
has license	cc-by-nc
sha1sum (hex)	d443900c4eef6494eeaf138236a955c0a040f3bd
schema:url	https://doi.org/10.3345/kjp.2017.60.4.112
resource representing a document's title	Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children
has PubMed Central identifier	PMC5410617
has PubMed identifier	28461824
schema:publication	Korean J Pediatr
resource representing a document's body	covid:d443900c4eef6494eeaf138236a955c0a040f3bd#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/d443900c4eef6494eeaf138236a955c0a040f3bd
is schema:about of	named entity 'groups' named entity 'Results' named entity 'Conclusion' named entity 'initial' named entity 'group' named entity 'Purpose' named entity 'levels' named entity 'procalcitonin' named entity 'INTRAVENOUS IMMUNOGLOBULIN' named entity 'DIFFERENTIATING' named entity 'HELP' named entity '28P' named entity 'ERYTHROCYTE SEDIMENTATION RATE' named entity 'EXAMINED' named entity 'METHODS' named entity 'PROTEIN ' named entity 'ESR' named entity 'PATIENTS' named entity 'BACTERIAL INFECTION' named entity 'GROUP' named entity 'B11' named entity 'CHILDREN' named entity 'INFECTIONS' named entity 'BACTERIAL' named entity 'PROCALCITONIN' named entity 'DISTINGUISHING' named entity 'FEBRILE' named entity 'LEVEL' named entity 'KAWASAKI DISEASE' named entity 'CHILDREN' named entity 'PROCALCITONIN' named entity 'B16' named entity 'RESULTS' named entity 'CLINICAL USEFULNESS' named entity 'LEVEL' named entity 'INFECTION GROUP' named entity 'SERUM' named entity 'PEDIATRIC' named entity 'CLINICAL USEFULNESS' named entity 'ASSESS' named entity 'DIVIDED' named entity 'PREDICTING' named entity 'MAY BE' named entity 'FEBRILE' named entity 'FOLLOWS' named entity 'PCT' named entity 'INCLUDING' named entity 'B10' named entity 'VIRAL INFECTION' named entity 'DIFFERENTIATE' named entity 'ADMITTED' named entity 'TREATMENT' named entity 'BACTERIAL INFECTIONS' named entity 'TO COMPARE' named entity 'HIGHER' named entity 'VIRAL' named entity 'KAWASAKI DISEASE' named entity 'USEFUL' named entity 'STUDY' named entity 'VIRAL INFECTIONS' named entity '111' named entity 'PROPORTION' named entity 'CONCLUSION' named entity 'INFECTIONS' named entity 'SERUM' named entity 'CRP' named entity 'GROUPS' named entity 'AUGUST' named entity 'LEVELS' named entity 'LOWER' named entity 'VIRAL AND' named entity '3E1' named entity 'INITIAL' named entity 'COMBINATION' named entity 'DISEASE MARKERS' named entity 'DIFFERENT' named entity 'MEAN'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software